Analystreport

Orchard Therapeutics plc (NASDAQ: ORTX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $15.00 price target on the sto

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report